首页 | 本学科首页   官方微博 | 高级检索  
     

缬沙坦对心力衰竭患者心功能及QT离散度的影响
引用本文:刘向儒,谭小军,张晓红,陈小亮,王仲华. 缬沙坦对心力衰竭患者心功能及QT离散度的影响[J]. 医药导报, 2003, 22(3): 156-158
作者姓名:刘向儒  谭小军  张晓红  陈小亮  王仲华
作者单位:湖南省郴州市第一人民医院心内科,423000
摘    要:目的:观察缬沙坦对扩张型心肌病(DCM)心力衰竭(心衰)患者心功能及QT离散度(QTd)的影响.方法:DCM心衰患者84例,分为两组.治疗组44例,用缬沙坦80 mg,qd,对照组40例,接受常规(包括卡托普利25 mg,bid)治疗,疗程均为1个月.两组治疗前后观察临床疗效,检查心脏彩色B超,同时检查心电图测量QTd.比较两组以上三方面变化.结果:治疗组在临床疗效、心功能变化及QTd变化方面明显优于对照组.结论:缬沙坦治疗DCM明显优于卡托普利,对于DCM心衰的患者,应早期尽快使用缬沙坦,这对于阻止心肌的进一步损伤,保护心脏功能,减少心律失常将起到有益的作用.

关 键 词:缬沙坦;心肌病  扩张型;QT离散度;力力衰竭
文章编号:1004-0781(2003)03-0156-03
修稿时间:2002-09-17

Effect of Valsartan on Heart Function and QT Dispersion in Patients with Heart Failure
LIU Xiang ru,TAN Xiao jun,ZHANG Xiao hong,CHEN Xiao liang,WANG Zhong hua. Effect of Valsartan on Heart Function and QT Dispersion in Patients with Heart Failure[J]. Herald of Medicine, 2003, 22(3): 156-158
Authors:LIU Xiang ru  TAN Xiao jun  ZHANG Xiao hong  CHEN Xiao liang  WANG Zhong hua
Abstract:Objective:To evaluate the effect of valsartan on QT dispersion and heart function in patients with dilated cardiomyopathy(DCM). Methods:Among the 84 DCM patients, 44 underwent valsartan treatment and 40 underwent captopril treatment. The QTd and heart function were observed and compared after 2 weeks. Results:The treatment group was superior to the control group in therapeutic effect, changes of heart function and changes of QTd. Conclusion:valsartan in treating DCM is batter than captopril in improving function of the left ventricle and reducing the occurrence of arrhythmias.
Keywords:Valsartan  Dilated cardiomyopathy  QT dispersion  Heart failure
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《医药导报》浏览原始摘要信息
点击此处可从《医药导报》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号